Executive Vice President and Chief Medical Officer
Pierre-Yves was appointed Chief Medical Officer in January 2023 and has responsibility for Medical Affairs, Pharmacovigilance, Quality Assurance, Value & Access and Bioethics activities.
Pierre-Yves brings extensive medical and scientific expertise to Ferring, having previously held the position of Senior Vice President, Head of Global Medical Affairs for Neurology and Immunology at Merck KGaA/EMD Serono, based in Boston, USA.
Prior to this, Pierre-Yves spent over 14 years at Eli Lilly, holding leadership roles in Medical Affairs, Global Clinical Development, Clinical Pharmacology and Discovery Research in multiple therapeutic areas, including immunology, neuroscience, diabetology and oncology. Pierre-Yves also spent seven years as Chief Medical Officer for Eli Lilly Japan, where he led the clinical and medical efforts in the successful launches of numerous new molecular entities (NMEs) and line extensions. His focus on safeguarding patients’ best interests has been a constant driver in his career.
